Swiss National Bank’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Swiss National Bank’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-119,700	Closed	-$2.13M	–	2556
2018 Q3	$2.13M	Buy	119,700 +23,600	+25%	+$405K	﹤0.01%	1681
2018 Q2	$1.33M	Buy	+96,100	New	+$1.14M	﹤0.01%	1991
2015 Q4	–	Sell	-58,100	Closed	-$266K	–	2673
2015 Q3	$266K	Hold	58,100	–	–	﹤0.01%	2430
2015 Q2	$302K	Hold	58,100	–	–	﹤0.01%	2447
2015 Q1	$364K	Buy	58,100 +5,600	+11%	+$32.3K	﹤0.01%	2331
2014 Q4	$330K	Buy	52,500 +20,900	+66%	+$127K	﹤0.01%	2365
2014 Q3	$192K	Hold	31,600	–	–	﹤0.01%	2444
2014 Q2	$208K	Hold	31,600	–	–	﹤0.01%	2465
2014 Q1	$752K	Buy	31,600 +9,900	+46%	+$144K	﹤0.01%	1875
2013 Q4	$232K	Hold	21,700	–	–	﹤0.01%	2359
2013 Q3	$289K	Sell	21,700 -1,700	-7%	-$26.9K	﹤0.01%	2235
2013 Q2	$307K	Buy	+23,400	New	+$316K	﹤0.01%	2208

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Swiss National Bank's ECYT Position: Q4 2018 in Review

Swiss National Bank sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 119,700 shares — an estimated $2.13M sold.

Swiss National Bank first reported a position in ECYT in Q2 2013 and held it in 12 quarters. The position peaked at $2.13M in Q3 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Swiss National Bank reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Swiss National Bank sold 119,700 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $2.13M.
Swiss National Bank first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 12 quarters.
Swiss National Bank's Endocyte, Inc. Common Stock position peaked at $2.13M in Q3 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Swiss National Bank's 13F filing for Q4 2018, filed 13 Feb 2019.